- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cardiology MDTV - Page 55
LIFE Trial: sacubitril/valsartan combination not effective to treat HF
The LIFE trial highlights that combination sacubitril/valsartan did not reduce N-terminal pro b-type natriuretic peptide...
Anemia a risk factor of Chronic Kidney Disease in kids
Anemia is a condition in which person lacks enough healthy red blood cells to carry adequate oxygen to your body's...
PARADISE MI Trial: sacubitril/valsartan effective for heart attack
The PARADISE -MI trial assesed the efficacy and safety of sacubitril/valsartan compared with ramipril in a...
Emperor preserved trial: Empagliflozin effective to treat heart...
The EMPEROR-Preserved trial reports empagliflozin is superior to placebo in improving heart failure outcomes among...
Dual antiplatelet therapy effective: MASTER DAPT Trial
Fatal heart diseases are most commonly caused by formation of clots in major blood vessels, its a serious risk...
Ras inhibitors affects kidney vessels to greater extent
Hypertension treatment is resulting in blood flow obstruction, focal ischemia, and fibrosis in kidney vessels....
Anxiety: a risk factor for cardiometabolic diseases in males
Men are usually considered emotionally strong and a strong misconception that they have no fear, anxiety a feeling...
Intra Atrial shunt is inefficient in preventing heart failure
Surgical interventions are used timely in need of emergency to manage cardiac diseases. More than one-half of...
Physical exercise to improve the risk of diabetes
Diabetes is a metabolic disease that causes imbalance in body metabolism, and improper blood glucose level management is...
Uncontrolled Diabetes increases heart failure risk in patients
Diabetes was associated with a very constant near 2-fold increase in the risk of heart failure with presentation...
Smoking cessation to improve heart's health
Smokers are at more risk for both lung and heart disorders. Time since smoking cessation was related to rising hs-cTnI...
Anxiety and depression improved by self care preventing heart failure
Mental health is equally important in maintaining a healthy life. Heart failure is one of the major concerns and...